Stay updated on Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site revision tag was updated from v3.6.3 to v3.6.4, indicating an updated version of the page's implementation.
    Difference
    0.0%
    Check dated 2026-07-25T18:15:34.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page header revision label was updated from v3.6.2 to v3.6.3, indicating a newer version of the page. This metadata update does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-04T10:06:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page shows a newer revision tag, updating from v3.6.0 to v3.6.2, indicating a newer version of the page is in use.
    Difference
    0.0%
    Check dated 2026-06-27T06:15:45.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed and adds new guidance sections for readers, while removing the old Intervention / Treatment heading and updating to revision v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-13T01:09:28.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a small backend/template update to render the study details.
    Difference
    0.0%
    Check dated 2026-06-05T21:48:26.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The study record now includes new date entries: a QC-verified update on 2026-05-11, a posted update on 2026-05-28, and an estimated study completion date of 2026-06-30. Older date entries from 2025 were removed, reflecting a refresh of the study timeline and recent activity.
    Difference
    0.2%
    Check dated 2026-05-29T23:24:34.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.